Sort   by:  
 Page size 
UnknownHow to Treat HR+/HER2- Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story.
Not available
S-EPMC8954717 | biostudies-literature
UnknownImmunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study.
Not available
S-EPMC9446532 | biostudies-literature
UnknownMetronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?
Not available
S-EPMC5733132 | biostudies-literature
Sort   by:  
 Page size